Understanding how Cx26 gene mutations lead to hearing loss
Connexin Function and Mechanisms of Cx26 Deficiency Induced Hearing Loss
['FUNDING_R01'] · YALE UNIVERSITY · NIH-11099661
This study is looking into how a gene called Cx26 causes different types of hearing loss, from being born deaf to developing hearing issues as a child, and it aims to find out how this gene affects the inner ear so we can better understand how to help people with hearing problems.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-11099661 on ClinicalTrials.gov |
What this research studies
This research investigates the role of the Cx26 gene in causing hereditary deafness, which can range from severe congenital deafness at birth to milder hearing loss that develops in childhood. By using mouse models, the researchers aim to uncover how Cx26 deficiency leads to cochlear developmental disorders and affects hearing. The study focuses on understanding the cellular and molecular mechanisms behind these changes, which could provide insights into potential treatments for affected individuals. The research also seeks to clarify why previous gene therapy attempts to restore hearing have not been successful.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a known genetic mutation in the Cx26 gene or those experiencing unexplained hearing loss.
Not a fit: Patients with hearing loss not related to Cx26 mutations or those with acquired hearing loss from non-genetic causes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and potential treatments for congenital and late-onset hearing loss caused by Cx26 mutations.
How similar studies have performed: While there have been studies on Cx26 and hearing loss, this research aims to provide new insights into the mechanisms of Cx26 deficiency, making it a novel approach.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHAO, HONG-BO — YALE UNIVERSITY
- Study coordinator: ZHAO, HONG-BO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.